.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Argus Health
Cipla
Citi
Baxter
Cerilliant
Covington
Harvard Business School
Chinese Patent Office
Dow

Generated: September 21, 2017

DrugPatentWatch Database Preview

Epinephrine bitartrate; etidocaine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for epinephrine bitartrate; etidocaine hydrochloride and what is the scope of epinephrine bitartrate; etidocaine hydrochloride patent protection?

Epinephrine bitartrate; etidocaine hydrochloride
is the generic ingredient in one branded drug marketed by Astrazeneca and Dentsply Pharm, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for epinephrine bitartrate; etidocaine hydrochloride.

Summary for Generic Name: epinephrine bitartrate; etidocaine hydrochloride

Tradenames:1
Patents:0
Applicants:2
NDAs:2
Drug Master File Entries: see list19
Clinical Trials: see list2,670
Drug Prices:see low prices
DailyMed Link:epinephrine bitartrate; etidocaine hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca
DURANEST
epinephrine bitartrate; etidocaine hydrochloride
INJECTABLE;INJECTION017751-007Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Astrazeneca
DURANEST
epinephrine bitartrate; etidocaine hydrochloride
INJECTABLE;INJECTION017751-006Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Dentsply Pharm
DURANEST
epinephrine bitartrate; etidocaine hydrochloride
INJECTABLE;INJECTION021384-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: epinephrine bitartrate; etidocaine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca
DURANEST
epinephrine bitartrate; etidocaine hydrochloride
INJECTABLE;INJECTION017751-006Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Astrazeneca
DURANEST
epinephrine bitartrate; etidocaine hydrochloride
INJECTABLE;INJECTION017751-007Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Astrazeneca
DURANEST
epinephrine bitartrate; etidocaine hydrochloride
INJECTABLE;INJECTION017751-007Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Astrazeneca
DURANEST
epinephrine bitartrate; etidocaine hydrochloride
INJECTABLE;INJECTION017751-006Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Chubb
QuintilesIMS
AstraZeneca
Covington
UBS
Federal Trade Commission
Cantor Fitzgerald
Teva
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot